Frontlight ResearchEarly access
Trial site
Centro de Salud e Investigaciones Médicas
- 7running trials
- 6closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Obesity7 trials
- Type 2 diabetes5 trials
- Chronic kidney disease2 trials
- Obstructive sleep apnoea2 trials
- Peripheral artery disease2 trials
- Stroke2 trials
- Type 1 diabetes2 trials
- COPD1 trial
- Coronary artery disease1 trial
- Heart failure1 trial
- High blood pressure1 trial
- Phase
- Phase 311 trials
- Phase 22 trials
- Status
- Completed6 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company13 trials
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease1 recruiting
- COPD1 recruiting
- High blood pressure1 recruiting
- Obesity1 recruiting
- Peripheral artery disease1 recruiting
- Stroke1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026